Testing effectiveness (Phase 2)Ended earlyNCT03945799
What this trial is testing
Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery Recurrence
Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 28